- Conditions
- Attention-Deficit/Hyperactivity Disorder, Comorbid Dyslexia
- Interventions
- Atomoxetine
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 10 Years to 16 Years
- Enrollment
- 105 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2006
- U.S. locations
- 8
- States / cities
- Rolling Hills Estate, California • Maitland, Florida • Miami, Florida + 5 more
Source: ClinicalTrials.gov public record
Updated Jan 25, 2007 · Synced May 22, 2026, 5:05 AM EDT